FDA Clearance Tracker · K250397
Helios Dermal Scaffold
Last checked: Nov 19, 2026Latest source record: Aug 15, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Aug 15, 2025
Substantially Equivalent
Time to decision
184 days
Received Feb 12, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Unclassified
The decision
- FDA number
- K250397
- Device name
- Helios Dermal Scaffold
- Applicant
- Helios Biomedical, Inc.
- Applicant location
- Weston, MA
- Received
- Feb 12, 2025
- Decided
- Aug 15, 2025
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Unclassified
- Specialty
- General & Plastic SurgeryWound Care
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code KGN. The earliest in FDA's data is K790496, decided May 3, 1979.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K250397
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Helios Biomedical, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K250420 · Decided May 14, 2025 · 90 days after receipt
Device type: Dura Substitute (GXQ) · Neurology & Neurosurgery
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.